Zobrazeno 1 - 10
of 322
pro vyhledávání: '"Stockschläder M"'
Autor:
Ghodsizad, A., Klein, H.-M., Borowski, A., Stoldt, V., Feifel, N., Voelkel, T., Piechaczek, C.H., Burchardt, E.R., Stockschläder, M., Gams, E.
Publikováno v:
In Cytotherapy October 2004 6(5):523-526
Publikováno v:
Haemophilia. Sep2011, Vol. 17 Issue 5, p808-814. 7p. 5 Graphs.
Autor:
Stockschläder M, H Bartels, H Renges, B Rüssmann, R. Kuse, N Kröger, W Krüger, G Wacker-Backhaus, N. Fuchs, M Dürken, Hartmut Kabisch, A R Zander, Rudolf Erttmann, S Hegewisch-Becker, Stefan S. Bielack, M de Wit, Gunter Schuch, D Braumann
Publikováno v:
Bone Marrow Transplantation. 22:1029-1033
We investigated an intensified conditioning regimen including fractionated total body irradiation (12 Gy), etoposide (30–45 mg/kg) and cyclophosphamide (120 mg/kg), followed by autologous (n = 5), allo-related (n = 13) or allo-unrelated (n = 6) bon
Autor:
W. Zeller, Axel R. Zander, H. T. Hassan, C. Krog, William Krüger, Stockschläder M, Rudolf Erttmann
Publikováno v:
Supportive Care in Cancer. 5:299-306
In the present single institution study of 66 leukaemia patients (28 AML, 23 ALL, 15 CML), the factors influencing haematological recovery after allogeneic bone marrow transplantation (alloBMT) were analysed retrospectively to identify the optimal co
Publikováno v:
STEM CELLS. 14:419-429
Allogeneic transplantation of selected CD34+ cells, rather than conventional transplantation of bone marrow (BM) harvest or peripheral blood (PB) leukapheresis products, has the advantage of reducing volume, facilitating storage and decreasing the am
Autor:
Peter Dreger, Stockschläder M, S Bittner, A R Zander, M. Hoffknecht, W Krüger, N Kröger, A Krüll, H.J. Weh, W. Zeller
Publikováno v:
Bone Marrow Transplantation. 21:55-57
In advanced stage mantle cell lymphoma, conventional chemotherapy yields a complete remission rate below 40%, and the median survival rate is only about 3 years. Between 1991 and 1996 we treated nine such patients (six male; three female) with high-d
Autor:
Schulte am Esch, J, Knoefel, WT, Klein, M, Ghodsizad, A, Fürst, G, Poll, LW, Stockschläder, M, Peiper, M, Hosch, SB
Publikováno v:
122. Kongress der Deutschen Gesellschaft für Chirurgie; 20050405-20050408; München; DOC05dgch3632 /20050615/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1175::5eef5692333586f8237dfbf824dd8c34
http://www.egms.de/en/meetings/dgch2005/05dgch674.shtml
http://www.egms.de/en/meetings/dgch2005/05dgch674.shtml
Publikováno v:
British Journal of Haematology. 92:1027-1029
Autor:
William Krueger, Stockschläder M, Judith Dierlamm, Axel R. Zander, Jürgen Berger, Nicolaus Kröger, Kai Gutensohn, Dieter K. Hossfeld, W. Zeller
Publikováno v:
Journal of hematotherapystem cell research. 8(5)
The yield of CD34+ PBPC and colony-forming units-granulocyte-macrophage (CFU-GM) in leukapheresis products and the expression of the adhesion molecules CD11a, CD31, CD49d, CD49e, CD54, CD58, CD62L, c-kit (CD117), Thy-1 (CD90), CD33, CD38, and HLA-DR
Autor:
M Hänel, H.J. Weh, Rudolf Erttmann, W. Zeller, N Kröger, A R Zander, Stockschläder M, M. Hoffknecht, W Krüger, M de Wit, Hartmut Kabisch
Publikováno v:
Bone marrow transplantation. 21(12)
Relapse after transplant for malignant lymphomas remains the main cause of treatment failure. Most conditioning regimens contain total body irradiation (TBI). We investigated the toxicity and efficacy of an intensified chemotherapy conditioning regim